Volume 120; Issue 6

Main
Blood
Volume 120; Issue 6

Blood

Volume 120; Issue 6

1

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol

Mahoney, E., Lucas, D. M., Gupta, S. V., Wagner, A. J., Herman, S. E. M., Smith, L. L., Yeh, Y.-Y., Andritsos, L., Jones, J. A., Flynn, J. M., Blum, K. A., Zhang, X., Lehman, A., Kong, H., Gurcan, M.,

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 1.13 MB

english, 2012

2

DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells

Hosszu, K. K., Valentino, A., Vinayagasundaram, U., Vinayagasundaram, R., Joyce, M. G., Ji, Y., Peerschke, E. I. B., Ghebrehiwet, B.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 625 KB

english, 2012

3

Intracellular cyclophilin A is an important Ca2+ regulator in platelets and critically involved in arterial thrombus formation

Elvers, M., Herrmann, A., Seizer, P., Munzer, P., Beck, S., Schonberger, T., Borst, O., Martin-Romero, F. J., Lang, F., May, A. E., Gawaz, M.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 696 KB

english, 2012

4

The B-cell receptor signaling pathway as a therapeutic target in CLL

Woyach, J. A., Johnson, A. J., Byrd, J. C.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 385 KB

english, 2012

5

Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery

Tanaka, T., Takahashi, K., Yamane, M., Tomida, S., Nakamura, S., Oshima, K., Niwa, A., Nishikomori, R., Kambe, N., Hara, H., Mitsuyama, M., Morone, N., Heuser, J. E., Yamamoto, T., Watanabe, A., Sato-

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 645 KB

english, 2012

6

Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4+ target cells

Yavlovich, A., Viard, M., Zhou, M., Veenstra, T. D., Wang, J. M., Gong, W., Heldman, E., Blumenthal, R., Raviv, Y.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 456 KB

english, 2012

7

Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells

Butler, J. M., Gars, E. J., James, D. J., Nolan, D. J., Scandura, J. M., Rafii, S.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 370 KB

english, 2012

8

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Pui, C.-H., Mullighan, C. G., Evans, W. E., Relling, M. V.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 340 KB

english, 2012

9

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies

Fuchs, T. A., Kremer Hovinga, J. A., Schatzberg, D., Wagner, D. D., Lammle, B.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 486 KB

english, 2012

10

Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

Verstovsek, S., Kantarjian, H. M., Estrov, Z., Cortes, J. E., Thomas, D. A., Kadia, T., Pierce, S., Jabbour, E., Borthakur, G., Rumi, E., Pungolino, E., Morra, E., Caramazza, D., Cazzola, M., Passamon

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 381 KB

english, 2012

11

Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension

Asosingh, K., Farha, S., Lichtin, A., Graham, B., George, D., Aldred, M., Hazen, S. L., Loyd, J., Tuder, R., Erzurum, S. C.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 660 KB

english, 2012

12

Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia

Greiner, J., Ono, Y., Hofmann, S., Schmitt, A., Mehring, E., Gotz, M., Guillaume, P., Dohner, K., Mytilineos, J., Dohner, H., Schmitt, M.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 470 KB

english, 2012

13

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515

Stopeck, A. T., Unger, J. M., Rimsza, L. M., LeBlanc, M., Farnsworth, B., Iannone, M., Glenn, M. J., Fisher, R. I., Miller, T. P.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 278 KB

english, 2012